9 completed, 1 recruiting, 1 unknown, 1 withdrawn. 12 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 12 | Completed 9, Recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Eye Infections, Bacterial: new trials by email Literature Review of Eye Infections, Bacterial trials Research Report on Eye Infections, Bacterial
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of SUM-191 for Patients With Bacterial Conjunctivitis SUM-191, Placebo - Bacterial Conjunctivitis | Phase 1 / Phase 2 | Recruiting | Senju USA, Inc. | 426 | 2026-06-25 | 2026-06-30 |
| Study to Evaluate the Safety and Tolerability of PRO-231 Versus VIGAMOXI® on the Ocular Surface of Healthy Subjects PRO-231, VIGAMOXI® - Ophthalmological Agent Toxicity, Bacterial Conjunctivitis | Phase 1 | Completed | Laboratorios Sophia S.A de C.V. | 37 | 2024-01-30 | 2025-06-15 |
| Safety and Immunogenicity of a Chlamydia Vaccine CTH522 CTH522-CAF01 IM, CTH522-CAF09b IM, CTH522 ID - Trachoma | Phase 1 | Completed | Statens Serum Institut | 65 | 2020-02-17 | 2024-08-22 |
| Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects PRO-174, Sophixín Ofteno® - Conjunctivitis, Conjunctivitis, Bacterial | Phase 1 | Completed | Laboratorios Sophia S.A de C.V. | 30 | 2018-01-25 | 2019-10-25 |
| Local Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers azithromycin eye drops by essex, azithromycin eye drops - Bacterial Conjunctivitis | Phase 1 | Unknown | Beijing Tongren Hospital | 56 | 2017-07-07 | 2017-08-01 |
| Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers. PRO-143 Ophthalmic Solution - Conjunctivitis, Bacterial | Phase 1 | Withdrawn | Laboratorios Sophia S.A de C.V. | 2013-11-01 | 2018-10-10 | |
| Systemic Pharmacokinetics of BOL-303224-A BOL-303224-A - Conjunctivitis, Bacterial | Phase 1 | Completed | Bausch & Lomb Incorporated | 24 | 2006-10-01 | 2011-12-09 |
| Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers Azithromycin - Eye Infections, Bacterial | Phase 1 | Completed | Laboratoires Thea | 2003-02-01 | 2006-07-26 | |
| Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers Azithromycin (T1225) - Eye Infections, Bacterial | Phase 1 | Completed | Laboratoires Thea | 2002-10-01 | 2006-07-27 | |
| Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers Azithromycin - Eye Infections, Bacterial | Phase 1 | Completed | Laboratoires Thea | 2002-05-01 | 2006-07-26 | |
| Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers Azithromycin (T1225) - Eye Infections, Bacterial | Phase 1 | Completed | Laboratoires Thea | 2002-03-01 | 2006-07-27 | |
| Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers Azithromycin (T1225) - Eye Infections, Bacterial | Phase 1 | Completed | Laboratoires Thea | 2002-02-01 | 2006-07-27 |
Conjunctivitis, Bacterial (6) · Chlamydia Infections (1) · Conjunctivitis (1) · Trachoma (1)
Bacterial Infections (12) · Bacterial Infections and Mycoses (12) · Eye Diseases (12) · Eye Infections (12) · Infections (12) · Conjunctival Diseases (7) · Conjunctivitis (6) · Chlamydiaceae Infections (1) · Communicable Diseases (1) · Conjunctivitis, Bacterial (1) · Corneal Diseases (1) · Genital Diseases (1) · Gram-Negative Bacterial Infections (1) · Sexually Transmitted Diseases (1)
Azithromycin (6) · Moxifloxacin (1) · Sodium Chloride (1) · apolipoprotein A-I Giessen (1) · besifloxacin (1)
Laboratoires Thea (5) · Laboratorios Sophia S.A de C.V. (3) · Bausch & Lomb Incorporated (1) · Beijing Tongren Hospital (1) · Senju USA, Inc. (1) · Statens Serum Institut (1)
Mexico (3) · United States (2) · China (1) · France (1) · United Kingdom (1)
Alejandra Sanchez-Rios, MD (1) · Alvaro Borges, MD (1) · Katrina Pollock, MD (1) · Lina S Stoey, MPH (1) · Pernille N Tingskov, BS (1) · Rebecca B Dohn, Pharm (1) · Xiuli Zhao (1)